mRNA-1012.1
/ Moderna
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
November 27, 2023
A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults
(clinicaltrials.gov)
- P1/2 | N=700 | Completed | Sponsor: ModernaTX, Inc. | Active, not recruiting ➔ Completed
Trial completion • Infectious Disease • Influenza • Respiratory Diseases
May 19, 2023
A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults
(clinicaltrials.gov)
- P1/2 | N=700 | Active, not recruiting | Sponsor: ModernaTX, Inc. | Recruiting ➔ Active, not recruiting
Enrollment closed • Infectious Disease • Influenza • Respiratory Diseases
April 24, 2023
A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults
(clinicaltrials.gov)
- P1/2 | N=700 | Recruiting | Sponsor: ModernaTX, Inc.
New P1/2 trial • Infectious Disease • Influenza • Respiratory Diseases
1 to 3
Of
3
Go to page
1